newsfilter
← Latest News
Business Wire·

AngioDynamics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • AngioDynamics, Inc. granted inducement awards to Eric Honroth upon his appointment as Chief Executive Officer effective November 2, 2026.
  • The awards were approved by the Compensation Committee to comply with Nasdaq Listing Rule 5635(c)(4).
  • Honroth received the First Sign-On Award consisting of 62,928 time-based restricted stock units vesting in equal annual installments over four years.
  • Honroth received the Second Sign-On Award consisting of 62,928 performance-based restricted stock units at the target level, with potential earnings ranging from 0% to 240% of target based on revenue, adjusted EBITDA, and total shareholder return over three years.
  • Honroth received the Third Sign-On Award consisting of 38,265 time-based restricted stock units vesting in two equal installments on November 2, 2027, and November 2, 2028.
  • All awards are subject to Honroth's continued service through each applicable vesting date.